
Amicus Therapeutics FOLD
Amicus Therapeutics Total Inventories | FOLD
Annual Total Inventories Amicus Therapeutics
| 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 | 2013 | 2012 | 2011 | 2010 | 2009 | 2008 | 2007 | 2006 | 2005 | 2004 | 2003 | 2002 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 229 M | 119 M | 59.7 M | 23.8 M | 26.8 M | 19.6 M | 14 M | 8.39 M | 4.62 M | 3.42 M | - | - | - | - | - | - | - | - | - | - | - | - | - | - |
All numbers in USD currency
Indicator range from annual reports
| Maximum | Minimum | Average |
|---|---|---|
| 229 M | 3.42 M | 50.8 M |
Quarterly Total Inventories Amicus Therapeutics
| 2025-Q4 | 2025-Q3 | 2025-Q2 | 2025-Q1 | 2024-Q4 | 2024-Q3 | 2024-Q2 | 2024-Q1 | 2023-Q4 | 2023-Q3 | 2023-Q2 | 2023-Q1 | 2022-Q4 | 2022-Q3 | 2022-Q2 | 2022-Q1 | 2021-Q4 | 2021-Q3 | 2021-Q2 | 2021-Q1 | 2020-Q4 | 2020-Q3 | 2020-Q2 | 2020-Q1 | 2019-Q4 | 2019-Q3 | 2019-Q2 | 2019-Q1 | 2018-Q4 | 2018-Q3 | 2018-Q2 | 2018-Q1 | 2017-Q4 | 2017-Q3 | 2017-Q2 | 2017-Q1 | 2016-Q4 | 2016-Q3 | 2016-Q2 | 2016-Q1 | 2015-Q4 | 2015-Q3 | 2015-Q2 | 2015-Q1 | 2014-Q4 | 2014-Q3 | 2014-Q2 | 2014-Q1 | 2013-Q4 | 2013-Q3 | 2013-Q2 | 2013-Q1 | 2012-Q4 | 2012-Q3 | 2012-Q2 | 2012-Q1 | 2011-Q4 | 2011-Q3 | 2011-Q2 | 2011-Q1 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 119 M | 119 M | 119 M | 119 M | 59.7 M | 115 M | 81.3 M | - | 59.7 M | 56.9 M | 51.4 M | 27 M | 23.8 M | 13.3 M | - | 24.3 M | 26.8 M | 22.1 M | 24.1 M | 18.8 M | 19.6 M | 19.6 M | 19.6 M | 19.6 M | 14 M | 14 M | 14 M | 14 M | 8.39 M | 8.39 M | 8.39 M | 8.39 M | 4.62 M | 4.62 M | 4.62 M | 4.62 M | 3.42 M | 3.42 M | 3.42 M | 3.42 M | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - |
All numbers in USD currency
Indicator range from quarterly reporting
| Maximum | Minimum | Average |
|---|---|---|
| 119 M | 3.42 M | 33.7 M |
Total Inventories of other stocks in the Biotechnology industry
| Issuer | Total Inventories | Price | % 24h | Market Cap | Country | |
|---|---|---|---|---|---|---|
|
Dynavax Technologies Corporation
DVAX
|
70.1 M | - | - | $ 2.02 B | ||
|
Qilian International Holding Group Limited
QLI
|
20.1 M | - | -6.08 % | $ 184 M | ||
|
Happiness Biotech Group Limited
HAPP
|
119 K | - | 1.35 % | $ 17.8 M | ||
|
Codexis
CDXS
|
1.82 M | $ 1.46 | 2.82 % | $ 127 M | ||
|
Ardelyx
ARDX
|
123 M | $ 3.78 | 1.89 % | $ 911 M | ||
|
Arcutis Biotherapeutics
ARQT
|
22.6 M | $ 23.9 | 1.01 % | $ 3.04 B | ||
|
AnPac Bio-Medical Science Co., Ltd.
ANPC
|
210 K | - | -1.58 % | $ 28.1 M | ||
|
Cyclacel Pharmaceuticals
CYCCP
|
1.38 M | - | -4.36 % | $ 27 M | ||
|
Axsome Therapeutics
AXSM
|
27.9 M | $ 206.68 | 0.16 % | $ 10.3 B | ||
|
BioMarin Pharmaceutical
BMRN
|
1.3 B | $ 66.53 | 0.15 % | $ 12.8 B | ||
|
BeiGene, Ltd.
BGNE
|
608 M | - | 0.49 % | $ 251 B | ||
|
ChromaDex Corporation
CDXC
|
9.19 M | - | -0.88 % | $ 598 M |